View Post

Impact of an Educational Program on Efficacy and Adherence with a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes, 34(2): 174-183.

In by AHFOctober 1, 2003